Table 2:

Patient demographics and clinical presentation

No.Age/SexMedical ComorbiditiesPresenting SymptomsBackground Treatment at PresentationInitial Treatment for Presenting Index EventAcute Infarcts on Prestent Brain MRI
168/FHypertension, hypothyroidismHemi-numbness, hemiparesis, dysarthriaNoneHeparinBilateral cerebellar, left parieto-occipital lobe
280/MHypertension, NIDDM, paroxysmal atrial fibrillation, ischemic coronary artery diseaseVertigo, ataxiaAspirin 81 mg/day, warfarin (INR 2.17 seconds)HeparinNone
376/MHypertension, tobacco abuse, dyslipidemiaVertigo, drop attacks/syncope, ataxia, dysarthria, blurred visionClopidogrelWarfarinNone
457/MHypertension, ischemic coronary artery diseaseHemiparesis, hemi-numbnessClopidogrel, aspirin 325 mg/daytPA, heparin, abciximabNone
583/FHypertension, ischemic coronary artery disease, congestive heart failure, hypothyroidismDysarthria, hemiparesisWarfarin (INR unknown)Heparin, aspirin 325 mg/dayNone
650/MNIDDM, dyslipidemia, tobacco and alcohol abuseHemiparesis, vertigo, dysarthria, ataxiaClopidogrel, aspirin 325 mg/day × 3 months after balloon angioplasty of Mori B lesion (70% stenosis with 25% residual stenosis)HeparinNo prestent brain MRI
761/MHypertension, NIDDM, alcohol abuseHomonymous hemianopsia, drop attacks/syncopeAspirin 325 mg/day × 4 months after acute thrombotic occlusion of basilar artery, 1 month after balloon angioplasty of Mori C lesion (90% stenosis with 50% residual stenosis)HeparinNone.
872/MHypertension, IDDM, dyslipidemia, paroxysmal atrial fibrillation, COPD, hypothyroidism, alcohol abuse, ischemic coronary artery diseaseVertigo, dysarthria, ataxiaClopidogrel, aspirin 325 mg/dayHeparinLeft cerebellar
969/MIschemic coronary artery disease, hypertensionDysarthria, hemiplegiaNoneClopidogrel, aspirin 325 mg/dayLeft hemi-pontine
1067/MHypertensionHemi-numbness, hemiparesisAspirin (dose unknown)Warfarin, aspirin 325 mg/dayNone
  • Note:—MRI indicates MR imaging; NIDDM, non–insulin-dependent diabetes mellitus; IDDM, insulin-dependent diabetes mellitus; COPD, chronic obstructive pulmonary disease; INR, international normalized ratio; sec, seconds; tPA, tissue plasminogen activator.